These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Metastatic melanoma: transplenic immunostimulation--a new therapeutical alternative for an ever-challenging disease. Lygidakis NJ; Safioleas M; Sgourakis G; Spentzouris N; Dedemadi G; Sotiropoulou P Hepatogastroenterology; 1999; 46(25):148-56. PubMed ID: 10228780 [TBL] [Abstract][Full Text] [Related]
5. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. Hingorani M; Calder VL; Buckley RJ; Lightman S Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598 [TBL] [Abstract][Full Text] [Related]
6. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus]. Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620 [TBL] [Abstract][Full Text] [Related]
7. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [TBL] [Abstract][Full Text] [Related]
8. [Identification of immunological effector cells after autologous cytokine-induced killer cells treatment and its clinical implication in hepatocellular carcinoma patients]. Shi M; Zhang B; Tang ZR; Lei ZY; Wang HF; Feng YY; Liu JC; Fan ZP; Li HW; Mu JS; Wang FS Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2049-53. PubMed ID: 14703414 [TBL] [Abstract][Full Text] [Related]
9. [The relationship between CD4(-) CD8(-) T cells in the peripheral blood of patients with pancreatic carcinoma and IL-4, IFN-gamma levels]. Chen J; Du M; Li WB; Lei C; Yang B; Tang HK; Zhai ZM; Ma JL; Li Q Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):995-8. PubMed ID: 19957810 [TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133 [TBL] [Abstract][Full Text] [Related]
11. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
12. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood? Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447 [TBL] [Abstract][Full Text] [Related]
13. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model. Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043 [TBL] [Abstract][Full Text] [Related]
14. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver. Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796 [TBL] [Abstract][Full Text] [Related]
15. [Arginine supplementation in total parenteral nutrition improves postoperative cellular immune function of patients with hepatocellular carcinoma after operation]. Zhou ZX; Zhang LJ; Huang XH; Kong QY; Zhou J Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1094-6. PubMed ID: 17666360 [TBL] [Abstract][Full Text] [Related]
16. In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients. Kountouras J; Boura P; Tsapas G Hepatogastroenterology; 1998; 45(24):2295-302. PubMed ID: 9951912 [TBL] [Abstract][Full Text] [Related]
17. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950 [TBL] [Abstract][Full Text] [Related]
18. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model. Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620 [TBL] [Abstract][Full Text] [Related]
19. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277 [TBL] [Abstract][Full Text] [Related]
20. Changes of immune function in patients with liver cirrhosis after splenectomy combined with resection of hepatocellular carcinoma. Cao ZX; Chen XP; Wu ZD Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):562-5. PubMed ID: 14627520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]